Evidence map›Paper›PMID 25552798›Full record

ArticleProceedings (Baylor University. Medical Center)2015

Lobular carcinoma of the breast with gastrointestinal metastasis.

Catherine Jones, Alex W Tong, Mariam Mir, Yvonne Coyle

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Rare sites of breast cancer metastasis: a review.Translational cancer research · 2019
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Catherine JonesDepartments of Hematology/Oncology (Jones) and Clinical Oncology Research (Tong), Charles A. Sammons Cancer Center at Dallas; Baylor Research Institute, Dallas, Texas (Tong); the Departments of Internal Medicine (Jones, Coyle) and Pathology (Mir), Baylor University Medical Center at Dallas; and Texas Oncology PA, Dallas, Texas (Coyle).
Alex W TongDepartments of Hematology/Oncology (Jones) and Clinical Oncology Research (Tong), Charles A. Sammons Cancer Center at Dallas; Baylor Research Institute, Dallas, Texas (Tong); the Departments of Internal Medicine (Jones, Coyle) and Pathology (Mir), Baylor University Medical Center at Dallas; and Texas Oncology PA, Dallas, Texas (Coyle).
Mariam MirDepartments of Hematology/Oncology (Jones) and Clinical Oncology Research (Tong), Charles A. Sammons Cancer Center at Dallas; Baylor Research Institute, Dallas, Texas (Tong); the Departments of Internal Medicine (Jones, Coyle) and Pathology (Mir), Baylor University Medical Center at Dallas; and Texas Oncology PA, Dallas, Texas (Coyle).
Yvonne CoyleDepartments of Hematology/Oncology (Jones) and Clinical Oncology Research (Tong), Charles A. Sammons Cancer Center at Dallas; Baylor Research Institute, Dallas, Texas (Tong); the Departments of Internal Medicine (Jones, Coyle) and Pathology (Mir), Baylor University Medical Center at Dallas; and Texas Oncology PA, Dallas, Texas (Coyle).
Baylor Institute for Rehabilitation · USBaylor University Medical Center · USTexas Oncology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present the case of a 74-year-old woman with metastatic lobular carcinoma with an occult breast primary presenting as a suspected ampullary tumor due to its ampullary metastasis. The patient's clinical presentation is of interest in two aspects. First, lobular carcinoma of the breast metastatic to the ampulla is extremely rare. Second, in the absence of a detectable primary lesion, prior history of malignancy, or distinguishing clinical, radiological, and endoscopic features, histopathological assessments are pivotal for arriving at the appropriate diagnosis and for optimizing treatment.

Identifiers

PMID25552798
PMCPMC4264710
OpenAlexW178860198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.